Brain edema is a common feature of several brain diseases(e.g.,stroke,traumatic brain injury,hydrocephalus,brain cancer,and brain infections).Brain edema leads to increased intracranial pressure and worsens outcomes i...Brain edema is a common feature of several brain diseases(e.g.,stroke,traumatic brain injury,hydrocephalus,brain cancer,and brain infections).Brain edema leads to increased intracranial pressure and worsens outcomes in ischemic stroke patients.Conventional treatments to control brain edema,thus reducing intracranial pressure include different osmotherapeutics,hyperventilation,tromethamine,hypothermia,and barbiturate coma.However,level 1 evidence of efficacy is lacking for these treatments,with some being harmful rather than beneficial(Bardutzky and Schwab,2007).It has been proposed aquaporin 4(AQP4)can be a novel drug target for treating brain edema(Vandebroek and Yasui,2020).展开更多
Alzheimer's disease(AD),a commonneurodegenerative disease,afflicts 26 million people worldwide currently with projection of a fourfold increase in this figure by the year 2050(Brookmeyer et al.,2018).The majority ...Alzheimer's disease(AD),a commonneurodegenerative disease,afflicts 26 million people worldwide currently with projection of a fourfold increase in this figure by the year 2050(Brookmeyer et al.,2018).The majority of AD cases(95%)are sporadic,having the late-onset affecting those over 65 years old.展开更多
基金supported by the NSW Ministry of Health, Australia under the NSW Health Early-Mid Career Fellowships Schemethe Australian Academy of Technology and Engineering(ATSE)under the Global Connections Fund+1 种基金supported by research grants received from the Wellcome Trust(200633/z/16/z)Keele University
文摘Brain edema is a common feature of several brain diseases(e.g.,stroke,traumatic brain injury,hydrocephalus,brain cancer,and brain infections).Brain edema leads to increased intracranial pressure and worsens outcomes in ischemic stroke patients.Conventional treatments to control brain edema,thus reducing intracranial pressure include different osmotherapeutics,hyperventilation,tromethamine,hypothermia,and barbiturate coma.However,level 1 evidence of efficacy is lacking for these treatments,with some being harmful rather than beneficial(Bardutzky and Schwab,2007).It has been proposed aquaporin 4(AQP4)can be a novel drug target for treating brain edema(Vandebroek and Yasui,2020).
基金a funding from the Petroleum Technology Development Fund,Nigeria。
文摘Alzheimer's disease(AD),a commonneurodegenerative disease,afflicts 26 million people worldwide currently with projection of a fourfold increase in this figure by the year 2050(Brookmeyer et al.,2018).The majority of AD cases(95%)are sporadic,having the late-onset affecting those over 65 years old.
